Literature DB >> 15313818

Immune reconstitution inflammatory syndrome associated with HIV and leprosy.

Pierre Couppié1, Sylvie Abel, Hélène Voinchet, Morgane Roussel, Raymond Hélénon, Michel Huerre, Dominique Sainte-Marie, André Cabié.   

Abstract

BACKGROUND: Immune reconstitution inflammatory syndrome (IRIS) is an unusual inflammatory reaction to an opportunistic infection that occurs in human immunodeficiency virus (HIV)-positive patients with profound immunosuppression during the reconstitution of the immune system in the initial months of highly active antiretroviral treatment. OBSERVATIONS: We describe 3 cases of leprosy occurring in patients treated with a combination of 3 antiretroviral drugs who fulfilled the criteria for IRIS. A reactional state occurred in all 3 cases. Two of the 3 patients presented an unusual ulcerous progression of the lesions not generally observed in cases of leprosy. The outcome was favorable in all 3 cases. The frequency of IRIS associated with leprosy in French Guiana and Martinique is estimated at 3 cases per 1000 HIV-positive patients receiving highly active antiretroviral treatment.
CONCLUSION: Leprosy should be recognized as an IRIS-associated infection with possibility of atypical presentation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313818     DOI: 10.1001/archderm.140.8.997

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  15 in total

1.  Leprosy after starting antiretroviral treatment.

Authors:  Stephen D Lawn; Diana N J Lockwood
Journal:  BMJ       Date:  2007-02-03

2.  Two patients coinfected with Mycobacterium leprae and human immunodeficiency virus type 1 and naive for antiretroviral therapy who exhibited type 1 leprosy reactions mimicking the immune reconstitution inflammatory syndrome.

Authors:  M A B Trindade; N Y S Valente; M I P Manini; M D F Takahashi; C F D Anjos; G Benard; B Naafs
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

3.  Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy.

Authors:  Alexia Cusini; Huldrych F Günthard; Rainer Weber; Milo Huber; Jivko Kamarashev; Barbara Bertisch; Silke Peter; Bernhard Beck
Journal:  BMJ Case Rep       Date:  2009-12-01

Review 4.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  HIV-M. leprae interaction: can HAART modify the course of leprosy?

Authors:  Euzenir Nunes Sarno; Ximena Illarramendi; José A Costa Nery; Anna M Sales; Maria C Gutierrez-Galhardo; Maria L Fernandes Penna; Elizabeth Pereira Sampaio; Gilla Kaplan
Journal:  Public Health Rep       Date:  2008 Mar-Apr       Impact factor: 2.792

6.  Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects.

Authors:  Karina I Carvalho; Solange Maeda; Luciana Marti; Jane Yamashita; Patrick A J Haslett; Esper G Kallas
Journal:  Immunology       Date:  2008-02-12       Impact factor: 7.397

7.  Human immunodeficiency virus and leprosy coinfection in Pune, India.

Authors:  Kulkarni Vinay; Joshi Smita; Gupte Nikhil; Gokhale Neeta
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

8.  Hansen's disease with HIV: a case of immune reconstitution disease.

Authors:  Dominic Chow; Leila Okinaka; Scott Souza; Cecilia Shikuma; Alan Tice
Journal:  Hawaii Med J       Date:  2009-03

9.  Role of CD8(+) T cells in triggering reversal reaction in HIV/leprosy patients.

Authors:  Ariane Leite de Oliveira; Thaís Porto Amadeu; Andressa Cristina de França Gomes; Vinícius Martins Menezes; José Augusto da Costa Nery; Roberta Olmo Pinheiro; Euzenir Nunes Sarno
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 10.  Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management.

Authors:  Devesh J Dhasmana; Keertan Dheda; Pernille Ravn; Robert J Wilkinson; Graeme Meintjes
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.